U.S. market Closed. Opens in 1 day 7 hours 6 minutes

DAWN | Day One Biopharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue383.00K531.00K199.00K155.00KN/A
Gross Profit-383.00K-531.00K-199.00K-155.00KN/A
Operating Expenses206.06M146.91M72.74M13.78M14.90M
Selling, General & Admin75.54M61.29M29.16M4.68M1.01M
Research & Development130.52M85.62M43.58M9.10M13.90M
Other Operating Expenses1.00-18.00K-15.00K-31.00K-2.00K
Operating Income-206.06M-146.91M-72.74M-13.78M-14.90M
Other Expenses / Income17.15M4.73M-11.00K-30.06M-2.08M
Before Tax Income-188.92M-142.18M-72.75M-43.84M-16.98M
Income Tax ExpensesN/A-10.01M-2.31M-3.34M-2.27M
Net Income-188.92M-132.18M-70.44M-40.51M-14.71M
Interest ExpensesN/A4.75M4.00K30.00K2.08M
Basic Shares Outstanding79.77M65.47M61.95M61.93M61.93M
Diluted Shares Outstanding79.77M65.47M61.95M61.93M61.93M
EBITDA-206.06M-141.65M-72.56M-43.66M-2.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-188.92M-137.44M-72.75M-43.81M-14.91M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙